Expression of Epstein-Barr Virus Latent Genes and Adhesion Molecules in AIDS-Related non-Hodgkin's Lymphomas: Correlation with Histology and CD4-Cell Number

References

• Zur Hausen H., Schule-Holthausen H., Klein G., et al. EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the oropharynx. Nature 1970; 228: 1056–1058
   PubMed Web of Science ®Google Scholar
• Weiss L.M., Movahed L.A., Warnke R.A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• van Gorp J., de Bruin P.C., Sie-Go D. M. D. S., van Heerde P., Ossenkoppele G.J., Rademakers L. H. P. M., Meijer C. J. L. M., van den Tweel J.G. Nasal T cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases. Histopathol 1995; 27: 139–148
   PubMed Web of Science ®Google Scholar
• Graig F.E., Gulley M.L., Banks P.M. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol 1993; 99: 265–276
   PubMed Web of Science ®Google Scholar
• Cohen J.I. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine 1991; 70: 137–160
   PubMed Web of Science ®Google Scholar
• Levine A.M. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80: 8–20
   PubMed Web of Science ®Google Scholar
• Anonymous. Opportunistic non-Hodgkin's lymphomas among severely immunocompromised HIV-infected patients surviving for prolonged periods on antiretroviral therapy-United States. MMWR 1991; 40: 591–600
   PubMedGoogle Scholar
• Knowles M.D., Chamulak G.A., Subar M., et al. Lymphoid neoplasia asociated with the acquired immunedefi-ciency syndrome (AIDS): The New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988; 108: 744–753
   PubMed Web of Science ®Google Scholar
• Kaplan L.D., Abrams D.I., Feigal E., et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261: 719–724
   PubMed Web of Science ®Google Scholar
• MacMahon E.M.E., Glass J.D., Hayward S.D., Mann R.B., Becker P.X., Charache P., McArthur J.C., Ambinder R.F. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991; 338: 969–973
   PubMed Web of Science ®Google Scholar
• Camilleri-Broet S., Davi F., Feuillard J., Bourgeois C., Seilhean D., Hauw J.J., Raphael M. High expression of Latent Membrane Protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in Acquired Immunodeficiency Syndrome-related primary brain lymphomas. Blood 1995; 86: 432–435
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S.J., Raphael M., Audoin J., Diebold J., Lisse I., Pedersen C., Oksenhendler E., Marelle L., Pallesen G. In situ demonstration of Epstein-Barr virus small RNA's (EBER 1) in Acquired Immunodeficiency Syndrome related lymphomas: correlation with tumor morphology and primary site. Blood 1993; 82: 619–624
   PubMed Web of Science ®Google Scholar
• Hamilton-Dutoit S.J., Rea D., Raphael M., Sandvej K., Delecluse H.J., Gisselbrecht C., Marelle L., van Krieken J. H. J. M., Pallesen G. Epstein-Barr virus-latent gene expression and tumor cell phenotype in Acquired Immunodeficiency Syndrome-related non-Hodgkin's lymphoma. Am J Pathol 1993; 143: 1072–1085
   PubMed Web of Science ®Google Scholar
• Carbone A., Tirelli U., Gloghini A., Volpe R., Boiocchi M. Human Immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 1993; 11: 1674–1681
   PubMed Web of Science ®Google Scholar
• Pedersen C., Gerstoft J., Lundgren J.D., Skinhoj P., Bottzauw J., Geisler C., Hamilton-Dutoit S.J., Thorsen S., Lisse I., Ralfkiaer E., Pallesen G. HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 1991; 27: 1416–1423
   PubMed Web of Science ®Google Scholar
• Birx D.L., Redfield R.R., Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 1986; 314: 874–879
   PubMed Web of Science ®Google Scholar
• Blumberg R.S., Paradis T., Byington R., Henle W., Hirsch M.S., Schooley R.T. Effects of Human Immunodeficiency Virus on the cellular immune response to Epstein-Barr virus in homosexual men: characterization of the cytotoxic response and lymphokine production. J Inf Dis 1987; 155: 877–890
   PubMed Web of Science ®Google Scholar
• Kersten M.J., Klein M.R., Holwerda A.M., Miedema F., van Oers M.H.J. EBV-specific cytotoxic T-cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma. J Clin Invest 1997; 99: 1525–1533
   PubMed Web of Science ®Google Scholar
• Lesley J., Hyman R., Kincade P.W. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271–335
   PubMed Web of Science ®Google Scholar
• Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., Bell J.I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160–12164
   PubMed Web of Science ®Google Scholar
• Horst E., Meijer C. J. L. M., Radaszkiewicz R., Ossekoppele G.J., van Krieken J. H. J. M., Pals S.T. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/CD18), and ICAM-1 (CD54). Leukemia 1990; 4: 595–599
   PubMed Web of Science ®Google Scholar
• Koopman G., Heider K.H., Horst E., Adolf G.R., v.d. Berg F., Ponta H., Herrlich P., Pals S.T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993; 127: 897–904
   Web of Science ®Google Scholar
• Stauder R., Eisterer W., Thaler J., Gunthert U. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 1995; 85: 2885–2899
   PubMed Web of Science ®Google Scholar
• Mulder J.W.R., Kruyt P.M., Sewnath M., Oosting J., Seldenrijk C.A., Weidema W.F., Offerhaus G.J.A., Pals S.T. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470–1472
   PubMed Web of Science ®Google Scholar
• Kaufmann M., Heider K.H., Sinn H.P., von Minckwitz G., Ponta H., Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615–619
   PubMed Web of Science ®Google Scholar
• Stansfeld A.G., Diebold J., Kapanci Y. Updated Kiel classification for lymphomas. Lancet 1988; i: 292–293
   Google Scholar
• The non-Hodgkin's lymphoma classification project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• van Gorp J., Weiping L., Jacobse K., Yong-Huei L., Feng-Yuan L., de Weger R.A., Li G. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J Pathol 1994; 173: 81–87
   PubMed Web of Science ®Google Scholar
• Pals S.T., Hogervorst F., Keizer G.D., Thepen T., Horst E., Figdor C.G. Identification of a widely distributed 90kD glycoprotein that is homologous to the Hermes-1 human lymphocyte homing receptor. J Immunol 1989; 13: 851–857
   Google Scholar
• Heider K.H., Hofmann M., Horst E., van den Berg F., Ponta H., Herrlich P., Pals S.T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120: 227–234
   PubMed Web of Science ®Google Scholar
• Neri A., Barriga F., Inghirami G., Knowles D.M., Neequaye J., Magrath I.T., Dalla-Favera R. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome associated lymphoma. Blood 1991; 77: 1092–1098
   PubMed Web of Science ®Google Scholar
• Shibata D., Weiss L.W., Hernandez A.M., Nathwani B.N., Bernstein L., Levine A.M. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the Human Immunodeficiency virus. Blood 1993; 81: 2102–2109
   PubMed Web of Science ®Google Scholar
• Billaud M., Rousset F., Calender A., Cordier M., Aubry J.P., Laisse V., Lenoir G.M. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. Blood 1990; 75: 1827–1833
   PubMed Web of Science ®Google Scholar
• Gregory C.D., Murray R.J., Edwards C.F., Rickinson A.B. Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumour cell escape from virus-specific cytotoxic T cell surveillance. J Exp Med 1988; 167: 1811–1824
   PubMed Web of Science ®Google Scholar
• Lombardi L., Newcomb E.W., Dalla-Favera R. Pathogenesis of Burkitt lymphomas: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 1987; 49: 161–167
   PubMed Web of Science ®Google Scholar
• Paganin C., Bianchi G., Lombardi L., Dalla-Favera R., Mantovani A., Allavena P. Role of leukocyte-function-associated antigen-1 and very late antigen-4 in the adhesion and transmigration of c-myc-transfected B-lymphoblastoid cell lines across vascular endothelium. Int J Clin Lab Res 1994; 24: 29–32
   PubMedGoogle Scholar
• Baldini L.G., Cro L.M. Structure and function of VLA integrins: differential expression in B cell leukemia/lymphoma. Leukemia and lymphoma 1994; 12: 197–203
   PubMed Web of Science ®Google Scholar
• Murray R.J., Kurilla M.G., Brooks J.M., Thomas W.A., Rowe M., Kieff E., Rickinson A.B. Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 1992; 176: 157–168
   PubMed Web of Science ®Google Scholar
• Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen. J. Nature 1995; 375: 685–688
   PubMed Web of Science ®Google Scholar
• Ballerini P., Gaidano G., Gong J.Z., Tassi V., Saglio G., Knowles D.M., Dalla-Favera R. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993; 81: 166–176
   PubMed Web of Science ®Google Scholar
• Haluska F.G., Russo G., Kant J., Andreef M., Croce C.M. Molecular resemblance of an AIDS-associated lymphoma and endemic Burkitt's lymphoma: implications for their pathogenesis. Proc Natl Acad Sci USA 1989; 86: 8907–8916
   PubMed Web of Science ®Google Scholar
• Whittle H.C., Brown J., Marsh K., Greenwood B.M., Seidelin P., Tighe H., Wedderburn L. T-cell control of Epstein-Barr virus-infected B-cells is lost during P. falciparum malaria. Nature 1984; 312: 449–452
   PubMed Web of Science ®Google Scholar
• Cen H., Williams P.A., McWilliams H.P., Breinig M.C., Ho M., McKnight J.L.C. Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with post-transplant lymphomproliferative disorders. Blood 1993; 81: 1393–1403
   PubMed Web of Science ®Google Scholar
• Wang F., Tsang S.F., Kurilla M.G., Cohen J.I., Kieff E. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP-1. J Virol 1990; 64: 3407–3416
   PubMed Web of Science ®Google Scholar
• Cordier M., Calender A., Billaud M. Stable transfection of Epstein-Barr virus nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B cell activation molecules CD21 and CD23. J Virol 1990; 64: 1002–1013
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C. Induction of bc12 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar
• Wang D., Liebowitz D., Wang F., Gregory C., Rickinson A., Larson R., Springer T., Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol 1988; 62: 4173–482
   PubMed Web of Science ®Google Scholar
• Walter J., Schirrmacher V., Mosier D. Induction of CD44 expression by the Epstein-Barr virus latent membrane protein LMP1 is associated with lymphoma dissemination. Int J Cancer 1995; 61: 363–369
   PubMed Web of Science ®Google Scholar
• Pals S.T., Meijer C. J. L. M., Radaszkiewicz T. Expression of the human peripheral lymph node homing receptor (LECAM-1) in nodal and gastrointestinal non-Hodgkin's lymphomas. Leukemia 1991; 5: 628–631
   PubMed Web of Science ®Google Scholar
• Jalkanen S., Bargatze R.Z., de los Toyos J., Butcher E.C. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 1987; 105: 983–990
   PubMed Web of Science ®Google Scholar
• Rothlein R., Dustin M.L., Marlin S.D., Springer T.A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986; 137: 1270–1274
   PubMed Web of Science ®Google Scholar
• Sanchez-Madrid F., de Landazuri M.O., Morago G., Cebrian M., Bernabeu C. VLA-4, a novel polypeptide associated with the VLA molecular complex: cellular distribution and biochemical characterization. Eur J Immunol 1986; 16: 1343–1349
   PubMed Web of Science ®Google Scholar